https://r428inhibitor.com/a-me....thod-to-relieve-fals
The goal of the study would be to investigate the prevalence of severe adverse outcomes also to determine the associated danger elements. This is a retrospective cohort study of pediatric oncology patients with febrile neutropenia from October 2013 to September 2017 at Thammasat University Hospital, Thailand. Clinical evaluation and time-to-event of extreme outcomes were reviewed. There were 95 febrile neutropenic episodes; extreme adverse outcomes had been documented in 11 (11.5%), wi
Like
Comment
Share
